| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 25178 | DS-1001b | 1898207-64-1 | ≧98.0% | ![]() |
| DS-1001 is an oral brain-penetrant mutant IDH1 selective inhibitor. | ||||
| 25177 | Dencatistat | 2377000-84-3 | ≧98.0% | ![]() |
| Dencatistat is an orally bioavailable, small molecule inhibitor of cytidine triphosph | ||||
| 25170 | DFV-890 (Synonyms: IFM-2427 ) | 2271394-34-2 | ≧98.0% | ![]() |
| DFV-890 is an oral, small-molecule inhibitor of the NLRP3 inflammasome. | ||||
| 25158 | DS68591889 | 2488609-21-6 | ≧98.0% | ![]() |
| DS68591889 (PTDSS1i) specifically inhibits PTDSS1, which catalyzes serine incorporati | ||||
| 25129 | 5,7-Difluoro-3-methylbenzofuran-2-carbaldehyde | 1784086-71-0 | ≧97.0% | ![]() |
| 25102 | 6,6-Dimethyl-4,5,6,7-tetrahydro-1H-indazole-3-carboxylic acid | 581083-30-9 | 98% Min. | ![]() |
| 25098 | 2,4-Dichloro-6-(2,2,2-trifluoroethyl)thieno[2,3-D]pyrimidine | 2055107-43-0 | ≧98.0% | ![]() |
| 25081 | Deucrictibant | 2340111-58-0 | 98% Min. | ![]() |
| 25056 | DHPG | 146255-66-5 | 98% Min. | ![]() |
| DHPG, also known as (RS)-3,5-DHPG, is a selective agonist for group I metabotropic gl | ||||
| 25037 | 1,3-dimethyl-1H-indazole-6-carbonitrile | 1516679-30-3 | 98% Min. | ![]() |
| 24096 | Deutivacaftor | 1413431-07-8 | 98% Min. | ![]() |
| Deutivacaftor, also known as CTP-656 and VX561, is a cystic fibrosis transmembrane co | ||||
| 24073 | Dabogratinib ( TYRA-300 ) | 2800223-30-5 | ≧98.0% | ![]() |
| Dabogratinib ( TYRA-300 ) is an Oral Selective FGFR3 Inhibitor (IC50 = 11 nM) for the | ||||
| 24060 | 2,4-dibromo-5-deuterothiazole | 960069-34-5 | 98% Min. | ![]() |
| 20596 | Denifanstat | 1399177-37-7 | 98% Min. | ![]() |
| TVB-2640 is an orally bioavailable fatty acid synthase (FASN) inhibitor, with potenti | ||||
| 20545 | 1,1-Dimethylethyl (1S,5S)-1-formyl-3-azabicyclo[3.1.0]hexane-3-carboxylate | 1932352-50-5 | 98% Min. | ![]() |
| 20544 | 1,1-Dimethylethyl (1R,5S)-1-ethynyl-3-azabicyclo[3.1.0]hexane-3-carboxylate | 1932410-93-9 | 98% Min. | ![]() |
| 20543 | 1,1-Dimethylethyl (1S,5S)-1-(hydroxymethyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate | 1932534-25-2 | 98% Min. | ![]() |
| 20538 | Danuglipron | 2230198-02-2 | 98% Min. | ![]() |
| Danuglipron, also known as PF-06882961 is a potent, orally bioavailable agonist of th | ||||
| 20520 | 4,5-diiodo-2-methyl-triazole | 859790-39-9 | 98% Min. | ![]() |
| 20498 | DSN28369 | 2413428-36-9 | 98% Min. | ![]() |
| DSN28369 is a heterobifunctional linker, and useful to make antibody drug conjuate (A | ||||
| 20497 | DSR-6434 | 1059070-10-8 | 98% Min. | ![]() |
| DSR-6434 is a potent TLR7 agonist (EC50 = 7.2 nM). DSR-6434 activates several immune | ||||
| 20489 | DASA-58 | 1203494-49-8 | 98% Min. | ![]() |
| DASa-58, also known as ML-203 and NCGC00185916, is a selective activator of pyruvate | ||||
| 20456 | DC-S100 | 178803-91-3 | 98% Min. | ![]() |
| DC-S100 is a selective histone methyltransferase SET7 inhibitor. | ||||
| 20442 | 4,5-Dichloroindole | 122509-73-3 | 98% Min. | ![]() |
| 20437 | Deruxtecan | 1599440-13-7 | 98% Min. | ![]() |
| Deruxtecan, a topoisomerase I inhibitor, is an exatecan derivative (DX-8951 derivativ | ||||
| 20434 | 4,6-dichloro-1H-pyrazolo[3,4-b]pyridine | 2105905-46-0 | 98% Min. | ![]() |
| 171654 | 2,5-Diamino-2,5-cyclohexadiene-1,4-dione | 1521-06-8 | 98% Min. | ![]() |
| G20379 | 2,6-DIFLUORO-4-[2-(PHENYLSULFONYLAMINO)E | 141286-78-4 | 98% Min. | ![]() |
| 20361 | 4,6-dimethylpyrazolo[1,5-a]pyrazine-2-carbaldehyde | 2407725-14-6 | 98% Min. | ![]() |
| 20324 | Diphenylterazine | 344940-63-2 | 98% Min. | ![]() |
| Diphenylterazine is a bioluminescence agent. Diphenylterazine alone yields very littl | ||||
Overnight Delivery
Fast & Safe Delivery Worldwide
Safety and Security
Intimate Service
Copyright 2015-2025 Wuhan Sun-shine Bio-technology Corporation Limited. | 鄂ICP备17005301号-1
